ENO2 and pancreatic serous cystadenoma: In another study of 24 PSC patients, only 2 (8.3%) presented with increased CEA levels, 2 (8.3%) with elevated CYFRA211 levels, 1 (4.2%) with increased SCCA level, and 1 (4.2%) with an increased NSE level (4).